Cullinan Therapeutics (CGEM) Other Accumulated Expenses (2021 - 2025)

Cullinan Therapeutics' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $996000.0 for Q4 2025.

• On a quarterly basis, Other Accumulated Expenses fell 30.69% year-over-year to $996000.0 in Q4 2025; TTM through Dec 2025 was $996000.0, a 30.69% decrease from a year earlier, with the FY2025 full-year figure at $996000.0, down 30.69% from the prior year.
• Other Accumulated Expenses fell to $996000.0 in Q4 2025 per CGEM's latest filing, from $1.4 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.0 million in Q4 2022 and bottomed at $914000.0 in Q4 2023.
• The 5-year median for Other Accumulated Expenses is $996000.0 (2025), against an average of $1.3 million.
• Across the five-year window, Other Accumulated Expenses soared 100.92% in 2022 and sank 53.25% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $973000.0 in 2021, then surged by 100.92% to $2.0 million in 2022, then sank by 53.25% to $914000.0 in 2023, then surged by 57.22% to $1.4 million in 2024, then slumped by 30.69% to $996000.0 in 2025.
• Per Business Quant, the three latest CGEM Other Accumulated Expenses figures stand at $996000.0 (Q4 2025), $1.4 million (Q4 2024), and $914000.0 (Q4 2023).